Kalpit Patel

Stock Analyst at B. Riley Securities

(0.80)
# 3,984
Out of 5,044 analysts
59
Total ratings
30.23%
Success rate
-12.11%
Average return

Stocks Rated by Kalpit Patel

Journey Medical
Jul 30, 2025
Maintains: Buy
Price Target: $9$12
Current: $8.13
Upside: +47.60%
Kymera Therapeutics
Jun 3, 2025
Upgrades: Buy
Price Target: $38$60
Current: $61.95
Upside: -3.15%
Bicycle Therapeutics
May 2, 2025
Maintains: Neutral
Price Target: $17$14
Current: $8.22
Upside: +70.32%
ArriVent BioPharma
Mar 20, 2025
Initiates: Buy
Price Target: $37
Current: $19.65
Upside: +88.30%
Rigel Pharmaceuticals
Mar 5, 2025
Maintains: Neutral
Price Target: $20$24
Current: $29.69
Upside: -19.16%
Geron
Feb 18, 2025
Maintains: Buy
Price Target: $5.5$3.5
Current: $1.28
Upside: +173.44%
Verastem
Jan 31, 2025
Maintains: Buy
Price Target: $7$9
Current: $8.85
Upside: +1.69%
Foghorn Therapeutics
Jan 30, 2025
Initiates: Buy
Price Target: $10
Current: $4.45
Upside: +124.72%
PDS Biotechnology
Nov 25, 2024
Maintains: Buy
Price Target: $9$7
Current: $0.93
Upside: +650.27%
Corbus Pharmaceuticals Holdings
Sep 20, 2024
Maintains: Buy
Price Target: $85$40
Current: $17.12
Upside: +133.64%
Maintains: Buy
Price Target: $9$3
Current: $1.49
Upside: +101.34%
Downgrades: Neutral
Price Target: $25$20
Current: $23.17
Upside: -13.68%
Downgrades: Neutral
Price Target: $90$30
Current: $3.81
Upside: +687.40%
Maintains: Buy
Price Target: $34$36
Current: $13.51
Upside: +166.47%
Downgrades: Neutral
Price Target: $270$90
Current: $2.10
Upside: +4,185.71%
Maintains: Buy
Price Target: $21$18
Current: $1.26
Upside: +1,328.57%
Maintains: Buy
Price Target: $6$5
Current: $2.52
Upside: +98.41%
Maintains: Buy
Price Target: $240$100
Current: $14.20
Upside: +604.47%
Downgrades: Neutral
Price Target: $75
Current: $13.46
Upside: +457.21%